<?xml version="1.0" encoding="utf-8"?>
<Journal>
<Journal-Info>
<name>International Journal of Pharma and Bio Sciences</name>
<website>ijpbs.net</website>
<email>editorijpbs@rediffmail.com (or) editorofijpbs@yahoo.com (or) prasmol@rediffmail.com</email>
</Journal-Info>
<article>
<article-id pub-id-type='other'>10.22376/ijpbs.2019.10.1.p1-12</article-id>
<issue_number>Volume 4 Issue 1</issue_number>
<issue_period>2013 (January - March)</issue_period>
<title>MICRODETERMINATION OF SILDENAFIL, TADALAFIL AND VARDENAFIL DRUGS EMPLOYED IN THE ERECTILE DYSFUNCTION THERAPY IN PHARMACEUTICAL FORMULATIONS AND URINE SAMPLES OF DIABETIC PATIENTS TYPE-II IN TAIF AREA, SAUDIA ARABIA USING ATOMIC EMISSION AND ATOMIC ABSORPTION SPECTROMETRY. </title>
<abstract>Ion – associate complexes of sildenafil, tadalafil and vardenafil hydrochlorides with [ Manganese(II) and Cobalt(II)] thiocyanates, potassium ferricyanide, sodium cobaltinitrite and ammonium reineckate were precipitated and the excess unreacted metal complex was determined. A new method using atomic emission and atomic absorption spectrometry for the determination of the above drugs in pure solutions, in pharmaceutical preparations and urine of diabetic patients type 2 was given. The drugs can be determined by the affort method in the ranges 0.56 - 104.28, 0.64 - 117.81 and 0.63 – 115.39 μg mL lessThan sup greaterThan -1 lessThan /sup greaterThan  solutions of Sd, Td and Vd, respectively.</abstract>
<authors>SABRY KH. MOHAMED  AND NAGLAA M. SHALABY</authors>
<keywords>Atomic emission, atomic absorption, ion-associate complexes, pharmaceutical analysis.</keywords>
<pages>1037-1046</pages>
</article>
</Journal>
